胃癌病理学及分子学发病机制.docxVIP

胃癌的病理学及分子学发病机制 HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors Author HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors Pelayo Correa, MD HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors Section Editor HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors Richard M Goldberg, MD HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors Deputy Editor HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors Diane MF Savarese, MD HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors 翻译 HYPERLINK /contents/zh-Hans/pathology-and-molecular-pathogenesis-of-gastric-cancer/contributors 李达, 副主任医师 Disclosures:?Pelayo Correa, MD?Nothing to disclose.?Richard M Goldberg, MD?Grant/Research/Clinical Trial Support: Sanofi [Colon cancer (Afibercept)]; Bayer [Colon cancer (Regorafinib)]; Medimmune [Colon cancer (Experimental agent)]; Merck [Colon cancer (PD-1 inhibitor MK-3475)]; Kanghong [Colon cancer (Experimental drug)]; Biothera [Colon cancer (Data Safety Monitoring Committee Chair for a phase III trial)]; Baxter [Colon cancer (Experimental drug)]; Taiho [Colon cancer (Experimental drug)]; Lilly [Colon cancer (Ramicurimab)].?Diane MF Savarese, MD?Nothing to disclose. 公开性原则:?李达, 副主任医师?没有透露。 编辑组会认真审核作者的声明。之间的利益冲突将会通过编辑组对文章以及参考文献的多级审评来解决。 所有的作者都必须提供与文章相关的文献，文章以及文献须严格依循UpToDate 的相关的标准。 HYPERLINK /%E5%88%A9%E7%9B%8A%E5%86%B2%E7%AA%81%E5%8E%9F%E5%88%99 \t _blank 利益矛盾的解决方案 我们的所有专题都会依据新发表的证据和 HYPERLINK /%E7%BC%96%E8%BE%91%E5%8E%9F%E5%88%99 \t _blank 同行评议过程而更新。 文献评审有效期至：?2015-12 .?|?专题最后更新日期：?2014-11-03. There is a newer version of this topic available in? HYPERLINK /contents/pathology-and-molecular-pathogenesis-of-gastric-cancer?source=Out+of+date+-+zh-Hanssearch=%E8%83%83%E7%99%8C%E4